SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark one)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2004
OR
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 0-28672
Optika Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 95-4154552 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
| 7450 Campus Drive, 2nd Floor Colorado Springs, CO |
80920 | |
| (Address of principal executive offices) | (Zip Code) | |
(719) 548-9800
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes ¨ No x
9,444,493 shares of the Registrants Common Stock, $.001 par value per share, were outstanding as of May 7, 2004
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
| March 31, 2004 |
December 31, 2003 |
|||||||
| (unaudited) | ||||||||
| Assets |
||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | 4,283 | $ | 3,929 | ||||
| Restricted cash and cash equivalents |
100 | 100 | ||||||
| Short-term investments |
5,153 | 5,153 | ||||||
| Accounts receivable, net |
4,475 | 4,696 | ||||||
| Other current assets |
462 | 523 | ||||||
| Total current assets |
14,473 | 14,401 | ||||||
| Property and equipment, net |
678 | 683 | ||||||
| Intangible assets, net |
559 | 584 | ||||||
| Goodwill |
1,166 | 1,166 | ||||||
| Other assets |
126 | 221 | ||||||
| $ | 17,002 | $ | 17,055 | |||||
| Liabilities and Stockholders Equity |
||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | 730 | $ | 510 | ||||
| Accrued expenses |
592 | 1,145 | ||||||
| Accrued compensation expense |
966 | 1,108 | ||||||
| Deferred revenue |
6,703 | 6,358 | ||||||
| Total current liabilities |
8,991 | 9,121 | ||||||
| Stockholders equity: |
||||||||
| Common stock; $.001 par value; 25,000,000 shares authorized; 9,436,993 and 9,327,061 shares issued and outstanding at March 31, 2004 and December 31, 2003, respectively |
9 | 9 | ||||||
| Series A-1 preferred stock; $.001 par value; 731,851 shares authorized, issued and outstanding |
5,199 | 5,199 | ||||||
| Additional paid-in capital |
30,647 | 30,491 | ||||||
| Accumulated deficit |
(27,844 | ) | (27,765 | ) | ||||
| Total stockholders equity |
8,011 | 7,934 | ||||||
| $ | 17,002 | $ | 17,055 | |||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except per share amounts)
| Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Revenues: |
||||||||
| Licenses |
$ | 1,873 | $ | 1,231 | ||||
| Maintenance and other |
3,749 | 3,115 | ||||||
| Total revenues |
5,622 | 4,346 | ||||||
| Cost of revenues: |
||||||||
| Licenses |
170 | 180 | ||||||
| Maintenance and other |
1,047 | 925 | ||||||
| Total cost of revenues |
1,217 | 1,105 | ||||||
| Gross profit |
4,405 | 3,241 | ||||||
| Operating expenses: |
||||||||
| Sales and marketing |
2,384 | 2,227 | ||||||
| Research and development |
1,164 | 1,191 | ||||||
| General and administrative |
570 | 399 | ||||||
| Merger related expenses |
417 | | ||||||
| Total operating expenses |
4,535 | 3,817 | ||||||
| Loss from operations |
(130 | ) | (576 | ) | ||||
| Other income, net |
51 | 18 | ||||||
| Loss before income tax provision |
(79 | ) | (558 | ) | ||||
| Income tax provision |
| | ||||||
| Net loss |
$ | (79 | ) | $ | (558 | ) | ||
| Basic and diluted net loss per common share |
$ | (0.01 | ) | $ | (0.07 | ) | ||
| Basic and diluted weighted average number of common shares outstanding |
9,370 | 8,351 | ||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
| Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Cash Flows From Operating Activities: |
||||||||
| Net loss |
$ | (79 | ) | $ | (558 | ) | ||
| Adjustments to reconcile net loss to net cash provided by operating activities: |
||||||||
| Depreciation and amortization |
112 | 131 | ||||||
| Changes in assets and liabilities: |
||||||||
| Accounts receivable, net |
221 | 733 | ||||||
| Other assets |
156 | (21 | ) | |||||
| Accounts payable |
220 | 71 | ||||||
| Accrued expenses and accrued compensation expense |
(695 | ) | (312 | ) | ||||
| Deferred revenue |
345 | 40 | ||||||
| Net cash provided by operating activities. |
280 | 84 | ||||||
| Cash Flows From Investing Activities: |
||||||||
| Capital expenditures |
(82 | ) | (54 | ) | ||||
| Net cash used by investing activities |
(82 | ) | (54 | ) | ||||
| Cash Flows From Financing Activities: |
||||||||
| Proceeds from issuance of common stock |
156 | 33 | ||||||
| Net cash provided by financing activities |
156 | 33 | ||||||
| Net increase in cash and cash equivalents |
354 | 63 | ||||||
| Cash and cash equivalents at beginning of period |
3,929 | 2,458 | ||||||
| Cash and cash equivalents at end of period |
$ | 4,283 | $ | 2,521 | ||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Basis of Presentations
The unaudited condensed consolidated financial statements included herein reflect all adjustments, consisting only of normal recurring adjustments, which in the opinion of management are necessary to fairly present our consolidated financial position, results of operations, and cash flows for the periods presented. Certain information and footnote disclosures normally included in audited financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the Securities and Exchange Commissions (SECs) rules and regulations. The consolidated results of operations for the period ended March 31, 2004 is not necessarily indicative of the results to be expected for any subsequent quarter or for the entire fiscal year ending December 31, 2004. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2003, included in the Annual Report on Form 10-K for the year ended December 31, 2003, as amended, of Optika Inc. (the Company).
2. Recent Developments
On January 12, 2004, we announced that we had entered into a definitive agreement to merge with Stellent, Inc. Under the terms of the merger agreement, each share of Optika common stock would be converted into .44 shares of Stellent common stock (subject to adjustment in certain circumstances as described below) and the holders of our preferred stock would receive $10 million in cash. If, based on the average closing price of Stellents common stock over a ten day period immediately prior to the closing of the merger, the .44 to one exchange ratio would result in our common stockholders receiving in excess of $4.00 per share of Stellent common stock, the exchange ratio will be adjusted so that 20% of the aggregate merger consideration in excess of $4.00 per share would be allocated to the holders of our preferred stock and 80% of the aggregate merger consideration in excess of $4.00 per share would be allocated to the holders of the common stock. The merger will be accounted for as a purchase transaction by Stellent and is expected to be completed late in the second calendar quarter of 2004. The closing is subject to regulatory approval, Optika and Stellent stockholder approval and customary closing conditions. In connection with the proposed merger, Stellent and Optika have filed a joint proxy statement/prospectus with the Securities and Exchange Commission. Investors and security holders of Stellent and Optika are urged to read the joint proxy statement/prospectus and other relevant materials as they become available because they will contain important information about Stellent, Optika and the proposed merger. Investors and security holders may obtain without charge copies of the joint proxy statement/prospectus and other relevant materials, and any other documents filed by Stellent or Optika with the Securities and Exchange Commission at the SECs web site at http://www.sec.gov. A free copy of the joint proxy statement/prospectus and other relevant materials, and any other documents filed by Stellent or Optika with the SEC, may also be obtained from Stellent and Optika. In addition, investors and security holders may access copies of the documents filed with the SEC by Stellent on Stellents website at www.Stellent.com. Investors and security holders may obtain copies of the documents filed with the SEC by Optika on Optikas website at www.Optika.com.
3. Net Loss Per Common Share and Stock Based Compensation
Net Loss Per Common Share
Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed using the weighted average number of common shares outstanding plus all dilutive potential common shares outstanding. During the first three months of 2004, 50,000 options to purchase our common stock were granted. During the first three months of 2003, 177,500 options to purchase our common stock were granted.
4
The following is the reconciliation of the numerators and denominators of the basic and diluted loss per share computations (in thousands, except per share data):
| Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Basic Loss Per Share |
||||||||
| Net loss |
$ | (79 | ) | $ | (558 | ) | ||
| Basic weighted average common shares outstanding |
9,370 | 8,351 | ||||||
| Basic net loss per common share |
$ | (0.01 | ) | $ | (0.07 | ) | ||
| Effect of Dilutive Securities: |
||||||||
| Options and warrants |
| | ||||||
| Diluted weighted average common shares outstanding |
9,370 | 8,351 | ||||||
| Diluted net loss per common share |
$ | (0.01 | ) | $ | (0.07 | ) | ||
In the first quarter of 2004 and 2003, 2,808,004 and 3,192,347, respectively, options and warrants were excluded from the dilutive stock calculation because of their antidilutive effect on net loss per share.
Stock-Based Compensation
We apply the intrinsic value-based method of accounting prescribed by Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations including FASB Interpretation No. 44, Accounting for Certain Transactions involving Stock Compensation, an interpretation of APB Opinion No. 25, to account for our fixed plan stock options. Under this method, compensation expense is recorded on the date of grant only if the current market price of the underlying stock exceeds the exercise price. SFAS No. 123, Accounting for Stock-Based Compensation, establishes accounting and disclosure requirements using a fair value-based method of accounting for stock-based employee compensation plans, as amended by SFAS No. 148, Accounting for Stock Based Compensation Transition and Disclosure an Amendment to SFAS 123. As allowed by SFAS No. 123, we have elected to continue to apply the intrinsic value-based method of accounting described above, and have adopted the disclosure requirements of SFAS No. 123, as amended by SFAS No. 148. Had compensation cost for our stock-based compensation plans been determined based on the fair value at the grant dates for awards under those plans consistent with the method of SFAS No. 123, our pro-forma net loss and pro-forma net loss per share would have been as follows:
| (In thousands, except per share data) |
||||||||
| Three Months Ended |
||||||||
| 2004 |
2003 |
|||||||
| Net loss: |
||||||||
| As reported |
$ | (79 | ) | $ | (558 | ) | ||
| SFAS No. 123 Pro-forma |
(237 | ) | (825 | ) | ||||
| Basic net loss per share |
||||||||
| As reported |
$ | (0.01 | ) | $ | (0.07 | ) | ||
| SFAS No. 123 Pro-forma |
(0.03 | ) | (0.10 | ) | ||||
| Diluted net loss per share: |
||||||||
| As reported |
$ | (0.01 | ) | $ | (0.07 | ) | ||
| SFAS No. 123 Pro-forma |
(0.03 | ) | (0.10 | ) | ||||
We estimate the fair value of each option grant on the date of grant using the Black-Scholes option-pricing model with the following assumptions used for grants in the first quarter of 2004 and 2003, respectively; no estimated dividends; expected volatility of 119% for 2004 and 121% for 2003 risk-free interest rates between 2.79% and 3.12% in 2004 and between 2.78% and 3.05% in 2003 and expected option terms of five years for both years.
5
4. Contingencies
We are, from time to time, subject to certain claims, assertions or litigation by outside parties as part of our ongoing business operations. The outcome of any such contingencies are not expected to have a material adverse effect upon our business, results of operations and financial condition. We are currently not a party to any material legal proceedings.
6
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This managements discussion and analysis of financial condition and results of operations includes a number of forward-looking statements which reflect our current views with respect to future events and financial performance. These forward-looking statements are subject to certain risks and uncertainties, including those discussed below and those under the caption Business Risks of Optika, that could cause actual results to differ materially from historical results or those anticipated.
Overview
Optika® Inc. is a leading provider of enterprise content management (ECM) technology, including document imaging, workflow, collaboration and records management software. Our Acorde family of ECM software solutions, including Acorde Context(TM), Acorde Process(TM), Acorde Resolve(TM), Acorde Application Link(TM) and Acorde Records Management(TM), allows companies to streamline their business processes, eliminate paper, increase operational efficiencies and effectively leverage their enterprise resource planning (ERP) and line-of-business (LOB) systems. Acorde provides the ability to manage compliance requirements, access and store multiple formats of business content, both digital and non-digital; automate processes across the organization and externally with partners and customers; and enable online collaboration around these paper-intensive or complex processes in real and near time. Acorde supports a wide spectrum of critical business operations, including accounts payable, accounts receivable, claims processing, expense reporting, records management and human resources.
Built on a three-tier, scalable and extensible platform, Acorde easily integrates and interfaces with third-party applications. Acorde is certified with PeopleSoft, J.D. Edwards and Microsoft Business Solutions, and has performed integrations with many other major ERP and LOB systems, including Oracle, SAP, JDA and Lawson. The Acorde product family makes extensive use of Web Services to ensure seamless movement of transaction data and documents between application and across the enterprise. The Acorde product allows organizations to improve processing efficiency, reduce operating costs and increase customer, partner, and employee service and satisfaction, resulting in a significant return on investment.
The license of our software products is typically an executive-level decision by prospective end-users and generally requires our sales staff and/or our Advantage Partners (APs) to engage in a lengthy and complex sales cycle (typically between six and twelve months from the initial contact date). We distribute our products through a direct sales force and a network of APs. For 2003, approximately 47% of our license revenues were derived from our APs and the remaining license fees were derived from direct sales. However, no individual customer or AP accounted for more than 10% of our total revenues. For the years ended December 31, 2003, 2002 and 2001, we generated approximately 10%, 9% and 12%, respectively, of our total revenues from international sales. Our revenues consist primarily of license revenues, which are comprised of one-time fees for the license of our products, service revenues, and maintenance revenues, which are comprised of fees for upgrades and technical support. Our APs, which are responsible for the installation and integration of the software for their customers, enter into sales agreements with the end-user, and license software directly from us. We license software directly to the end-user through software license agreements. Annual maintenance agreements are also entered into between the APs and the end-user, and the APs then purchase maintenance services directly from us. For 2003, 2002 and 2001, approximately 34%, 32% and 38%, respectively, of our total revenues were derived from software licenses and approximately 47%, 43% and 43%, respectively, of our total revenues were derived from maintenance agreements. For 2003, 2002 and 2001, other revenues, which are comprised of training, consulting and implementation services, and third-party hardware and software products, accounted for 19%, 25% and 19%, respectively, of our total revenues.
Critical Accounting Policies
Our significant accounting policies are described in Note 1 in the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2003, as amended. The accounting
7
policies used in preparing our interim consolidated financial statements for the three months ended March 31, 2004 are the same as those described in our Annual Report on Form 10-K,